Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01470105 · ClinicalTrials.gov registry record
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
A clinical trial of Bone Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 230
- Enrollment target
- 2
- Study locations
NCT01470105 is a study of Bone Metastases that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 230 participants, above the 131-participant average among 10 other Bone Metastases trials with a reported enrollment target (76% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT01470105, a study of Bone Metastases, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 230 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to improve how we estimate survival of people with cancer that has spread to their bone. There have been previous attempts to estimate survival of people with cancer that spread to the bone, but they have not been accurate. This study will try to improve the way we estimate survival in people with cancer that has spread to their bone by looking to see if a physician assessment and a patient assessment of the health status can be blended to give a better estimate of survival than patients or doctors alone.
Conditions Studied
Interventions
- OTHER blood sampling, the SF-36 questionnaire
Study Locations (2)
New York
- Memorial Sloan Kettering Cancer Center - New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2011-11 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01470105
The ClinicalTrials.gov registry entry for NCT01470105 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 131-participant average among 10 other Bone Metastases trials with a reported enrollment target (76% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Metastases appearing as the primary indexed condition, and to 1 intervention - of which blood sampling, the SF-36 questionnaire is the first listed.
NCT01470105 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01470105 about?
NCT01470105 is a clinical study titled "Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases". The goal of this study is to improve how we estimate survival of people with cancer that has spread to their bone. There have been previous attempts to estimate survival of people with cancer that spread to the bone, but they have not been accurate. This study will try to improve the way we estimate...
What is the current status of trial NCT01470105?
This trial is currently active not recruiting. The enrollment target is 230 participants. The study started on 2011-11. Estimated completion is 2026-11.
What conditions does trial NCT01470105 study?
This clinical trial studies the following conditions: Bone Metastases.
What interventions are being tested in trial NCT01470105?
The interventions under investigation include: blood sampling, the SF-36 questionnaire (OTHER).
Who is sponsoring clinical trial NCT01470105?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01470105 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Registry for Bone Metastases
RECRUITING
-
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
RECRUITING · NA
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
RECRUITING · Phase 3
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.